插管配置对ECMO桥接肺移植的影响:ELSO登记分析
基于ELSO登记2010–2022年1066例成人ECMO桥接肺移植患者,按静脉-静脉或静脉-动脉支持分层。ECMO桥接肺移植例数及出院生存率均随时间增加,总生存率87.7%。静脉-静脉组并发症更少、住院死亡率更低(11.0% vs 18.5%,P=.005);中心ECMO桥接肺移植总量增加对住院死亡有保护作用。
要点
- 静脉-静脉ECMO桥接肺移植的住院死亡率低于静脉-动脉(11.0% vs 18.5%,P=.005)。
- 静脉-静脉组透析、卒中和肢体缺血发生率均显著低于静脉-动脉组。
- 中心ECMO桥接肺移植总量增加对住院死亡有保护作用,约45例后获益。
核心结论
- ECMO桥接肺移植改善了移植后出院生存,总生存率为87.7%。
- 静脉-静脉ECMO较静脉-动脉ECMO并发症更少且住院死亡率更低。
- 选择静脉-动脉ECMO桥接肺移植时应审慎评估患者候选资格。
研究设计与样本
- 回顾性登记分析,使用体外生命支持组织(ELSO)登记数据。
- 纳入2010–2022年接受ECMO桥接肺移植的成人患者共1066例。
- 按静脉-静脉或静脉-动脉支持类型进行分层比较。
主要发现
- 研究期间ECMO桥接肺移植例数增加(P < .001),出院生存率亦增加(P < .001)。
- 静脉-静脉组透析16.7% vs 25.3%(P = .006),卒中1.4% vs 5.1%(P = .004),肢体缺血0.2% vs 3.4%(P < .001)。
- 静脉-静脉组术后需ECMO更少(41.0% vs 53.4%,P = .002),ECMO时间更短(4天[IQR 2-7] vs 5天[IQR 3-9],P = .01)。
- 静脉-静脉组住院死亡率显著低于静脉-动脉组(11.0% vs 18.5%,P = .005)。
- 中心ECMO桥接肺移植总量增加对住院死亡有保护作用(P < .001),约45例桥接意图插管后可见获益。
临床怎么用
- 在桥接肺移植中优先考虑静脉-静脉ECMO策略以减少并发症和死亡。
- 采用静脉-动脉ECMO桥接肺移植时应审慎评估患者候选资格。
- 中心开展ECMO桥接肺移植达到一定累积量后可能改善住院生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Donor stagnation and modification of lung allocation scores has resulted in a higher acuity of patient presentation before lung transplantation. Extracorporeal membrane oxygenation (ECMO) has been used as a bridge to lung transplant (BTT), although the effect of cannulation strategy on outcomes has not been well investigated. We analyzed contemporary data on ECMO BTT by using a large, international registry of patients. METHODS: We used the Extracorporeal Life Support Organization registry to identify all adult patients from 2010 to 2022 undergoing ECMO as a BTT. Patients were stratified by venovenous or venoarterial support type. RESULTS: A total of 1066 patients were identified. ECMO BTT increased over the study period (P < .001), as did survival to hospital discharge (P < .001), with an overall survival of 87.7%. Venovenous patients experienced fewer complications on ECMO, including dialysis (16.7% vs 25.3%, P = .006), stroke (1.4% vs 5.1%, P = .004), and limb ischemia (0.2% vs 3.4%, P < .001) and required ECMO less frequently in the postoperative period (41.0% vs 53.4%, P = .002) and for less time (4 days [interquartile range, 2-7 days] vs 5 days [interquartile range, 3-9 days], P = .01). In-hospital mortality was significantly lower for venovenous patients compared with venoarterial patients (11.0% vs 18.5%, P = .005). Increasing center volume of ECMO BTT was protective of in-hospital mortality (P < .001), with benefit observed after ∼45 total BTT intent cannulations. CONCLUSIONS: ECMO BTT has resulted in improved posttransplant survival to discharge. Owing to a higher rate of complications and worsened mortality, thoughtful implementation of venoarterial ECMO in BTT should be undertaken when assessing patient candidacy.
引用
- Wisniewski AM, Suzuki Y, El Moheb M, et al. Cannulation Configuration and Its Effects on Bridging to Lung Transplant: Analysis of the Extracorporeal Life Support Organization Registry. Ann Thorac Surg. 2024. PMID: 39725254. doi:10.1016/j.athoracsur.2024.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。